The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banaiee, N.
Right arrow Articles by Ernst, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banaiee, N.
Right arrow Articles by Ernst, J. D.
The Journal of Immunology, 2006, 176: 3019-3027.
Copyright © 2006 by The American Association of Immunologists

Potent Inhibition of Macrophage Responses to IFN-{gamma} by Live Virulent Mycobacterium tuberculosis Is Independent of Mature Mycobacterial Lipoproteins but Dependent on TLR21

Niaz Banaiee2,*, Eleanor Z. Kincaid2,*,{dagger}, Ulrike Buchwald*, William R. Jacobs, Jr.{ddagger} and Joel D. Ernst3,*,{dagger},§

* Department of Medicine, Division of Infectious Diseases, New York University School of Medicine, New York, NY 10016; {dagger} Biomedical Sciences Graduate Program, University of California, San Francisco, CA 94143; {ddagger} Howard Hughes Medical Institute and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461; and § Department of Microbiology, New York University School of Medicine, New York, NY 10016

Mycobacterium tuberculosis is a highly successful pathogen that can persist and cause disease despite an immune response. One potential mechanism for resisting elimination is by inhibiting the action of IFN-{gamma}. We have previously shown that live M. tuberculosis inhibits selected macrophage responses to IFN-{gamma}, and that purified M. tuberculosis 19-kDa lipoprotein inhibits induction of selected IFN-{gamma}-responsive genes through a TLR2-dependent pathway, whereas peptidoglycan inhibits responses to IFN-{gamma} by a TLR2-independent pathway. To determine the relative contribution of lipoproteins to the inhibition of responses to IFN-{gamma}, we deleted the M. tuberculosis gene (lspA) that encodes lipoprotein signal peptidase. This revealed that M. tuberculosis lipoprotein processing is indispensable for stimulation of TLR2 reporter cells, but that the lspA mutant inhibits macrophage responses to IFN-{gamma} to the same extent as wild-type bacteria. Macrophages lacking TLR2 are more resistant to inhibition by either strain of M. tuberculosis, suggesting that nonlipoprotein TLR2 agonists contribute to inhibition. Indeed, we found that phosphatidylinositol mannan from M. tuberculosis inhibits macrophage responses to IFN-{gamma}. M. tuberculosis inhibition of responses to IFN-{gamma} requires new protein synthesis, indicating that a late effect of innate immune stimulation is the inhibition of responses to IFN-{gamma}. These results establish that M. tuberculosis possesses multiple mechanisms of inhibiting responses to IFN-{gamma}.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Jeyanathan, J. Mu, K. Kugathasan, X. Zhang, D. Damjanovic, C. Small, M. Divangahi, B. J. Petrof, C. M. Hogaboam, and Z. Xing
Airway Delivery of Soluble Mycobacterial Antigens Restores Protective Mucosal Immunity by Single Intramuscular Plasmid DNA Tuberculosis Vaccination: Role of Proinflammatory Signals in the Lung
J. Immunol., October 15, 2008; 181(8): 5618 - 5626.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
S. K. Rampini, P. Selchow, C. Keller, S. Ehlers, E. C. Bottger, and P. Sander
LspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrest
Microbiology, October 1, 2008; 154(10): 2991 - 3001.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Narayana and K. N. Balaji
NOTCH1 Up-regulation and Signaling Involved in Mycobacterium bovis BCG-induced SOCS3 Expression in Macrophages
J. Biol. Chem., May 2, 2008; 283(18): 12501 - 12511.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Sieling, P. J. Hill, K. M. Dobos, K. Brookman, A. M. Kuhlman, M. Fabri, S. R. Krutzik, T. H. Rea, D. G. Heaslip, J. T. Belisle, et al.
Conserved Mycobacterial Lipoglycoproteins Activate TLR2 but Also Require Glycosylation for MHC Class II-Restricted T Cell Activation
J. Immunol., May 1, 2008; 180(9): 5833 - 5842.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Bastian, T. Braun, H. Bruns, M. Rollinghoff, and S. Stenger
Mycobacterial Lipopeptides Elicit CD4+ CTLs in Mycobacterium tuberculosis-Infected Humans
J. Immunol., March 1, 2008; 180(5): 3436 - 3446.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. J. Wolf, L. Desvignes, B. Linas, N. Banaiee, T. Tamura, K. Takatsu, and J. D. Ernst
Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs
J. Exp. Med., January 21, 2008; 205(1): 105 - 115.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. J. Weiss, C. D. Souza, O. A. Evanson, M. Sanders, and M. Rutherford
Bovine monocyte TLR2 receptors differentially regulate the intracellular fate of Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium
J. Leukoc. Biol., January 1, 2008; 83(1): 48 - 55.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Z. Kincaid, A. J. Wolf, L. Desvignes, S. Mahapatra, D. C. Crick, P. J. Brennan, M. S. Pavelka Jr., and J. D. Ernst
Codominance of TLR2-Dependent and TLR2-Independent Modulation of MHC Class II in Mycobacterium tuberculosis Infection In Vivo
J. Immunol., September 1, 2007; 179(5): 3187 - 3195.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
N. Banaiee, W. R. Jacobs, and J. D. Ernst
LspA-independent action of globomycin on Mycobacterium tuberculosis
J. Antimicrob. Chemother., August 1, 2007; 60(2): 414 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
H. S. Gibbons, F. Wolschendorf, M. Abshire, M. Niederweis, and M. Braunstein
Identification of Two Mycobacterium smegmatis Lipoproteins Exported by a SecA2-Dependent Pathway
J. Bacteriol., July 15, 2007; 189(14): 5090 - 5100.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Johnson, E. A. Lyle, K. O. Omueti, V. A. Stepensky, O. Yegin, E. Alpsoy, L. Hamann, R. R. Schumann, and R. I. Tapping
Cutting Edge: A Common Polymorphism Impairs Cell Surface Trafficking and Functional Responses of TLR1 but Protects against Leprosy
J. Immunol., June 15, 2007; 178(12): 7520 - 7524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. W. Yew and C. C. Leung
Update in Tuberculosis 2006
Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 541 - 546.
[Full Text] [PDF]


Home page
MicrobiologyHome page
M. Rezwan, T. Grau, A. Tschumi, and P. Sander
Lipoprotein synthesis in mycobacteria
Microbiology, March 1, 2007; 153(3): 652 - 658.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.